The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Associations between biomarkers and outcomes of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC).
B. H. Grønberg
Honoraria - Lilly
Research Funding - Lilly
M. Lund-Iversen
No relevant relationships to disclose
E. H. Strøm
Honoraria - Lilly
O. T. Brustugun
No relevant relationships to disclose
H. Scott
No relevant relationships to disclose